Ownership
Private
Employees
~50
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Avila Herbals General Information
Avila Herbals has conducted clinical investigations that were cited in FDA warning letters for procedural issues. The company has developed oleander-based products and has agreements with Phoenix Biotechnology for manufacturing and R&D.
Contact Information
Primary Industry
Biotech
Corporate Office
Christiansburg, Virginia
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Phoenix Biotechnology (exclusive global manufacturing and R&D agreements)
Avila Herbals Funding
No funding data available
To view Avila Herbals's complete valuation and funding history, request access »
Gosset